These results are consistent with the previous report [13] regarding the identification of a splicing defect in the MRE11 precursor transcript linked to mutations by a poly(T)11 repeat within intervening sequence 4 (IVS-4), exclusively in MMR-deficient cancer cell lines and primary tumors. Here, MRC1 is linked to cancer.